171 related articles for article (PubMed ID: 1952849)
1. Failure of beta-lactam antibiotics and marked efficacy of fluoroquinolones in treatment of murine Yersinia pseudotuberculosis infection.
Lemaitre BC; Mazigh DA; Scavizzi MR
Antimicrob Agents Chemother; 1991 Sep; 35(9):1785-90. PubMed ID: 1952849
[TBL] [Abstract][Full Text] [Related]
2. Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.
Bonacorsi SP; Scavizzi MR; Guiyoule A; Amouroux JH; Carniel E
Antimicrob Agents Chemother; 1994 Mar; 38(3):481-6. PubMed ID: 8203841
[TBL] [Abstract][Full Text] [Related]
3. Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection.
Scavizzi MR; Alonso JM; Philippon AM; Jupeau-Vessieres AM; Guiyoule A
Antimicrob Agents Chemother; 1987 Apr; 31(4):523-6. PubMed ID: 3475033
[TBL] [Abstract][Full Text] [Related]
4. Subpopulations of Stressed Yersinia pseudotuberculosis Preferentially Survive Doxycycline Treatment within Host Tissues.
Raneses JR; Ellison AL; Liu B; Davis KM
mBio; 2020 Aug; 11(4):. PubMed ID: 32753491
[TBL] [Abstract][Full Text] [Related]
5. [Yersinia pseudotuberculosis sensitivity to fluoroquinolones and the efficacy of pefloxacin in experimental pseudotuberculosis].
Zaĭtseva EA; Shubin FN; Besednova NN
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):49-52. PubMed ID: 9432847
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial susceptibility of Yersinia enterocolitica and Yersinia pseudotuberculosis strains isolated from humans in Poland during 2004-2009].
Szych J; Jakubczak A; Wardak S; Madajczak G
Med Dosw Mikrobiol; 2009; 61(4):311-9. PubMed ID: 20201320
[TBL] [Abstract][Full Text] [Related]
7. Detection, seroprevalence and antimicrobial resistance of Yersinia enterocolitica and Yersinia pseudotuberculosis in pig tonsils in Northern Italy.
Bonardi S; Bruini I; D'Incau M; Van Damme I; Carniel E; Brémont S; Cavallini P; Tagliabue S; Brindani F
Int J Food Microbiol; 2016 Oct; 235():125-32. PubMed ID: 27500659
[TBL] [Abstract][Full Text] [Related]
8. [INTESTINAL FAILURE AND YERSINIA PSEUDOTUBERCULOSIS TRANSLOCATION IN THE DEVELOPMENTOF EXPERIMENTAL GENERALIZED INFECTION].
Chicherin IY; Pogorelky IP; Lundovskikh IA; Darmov IV; Gorshkov AS; Shabalina MR
Eksp Klin Gastroenterol; 2016; (3):24-31. PubMed ID: 27301139
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility and distribution of β-lactamase A (blaA) and β-lactamase B (blaB) genes in enteropathogenic Yersinia species.
Bonke R; Wacheck S; Stüber E; Meyer C; Märtlbauer E; Fredriksson-Ahomaa M
Microb Drug Resist; 2011 Dec; 17(4):575-81. PubMed ID: 21970627
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of the antimicrobial activity of pefloxacin, ciprofloxacin, norfloxacin and azithromycin with respect to Strains of Yersinia pseudotuberculosis].
Zaĭtseva EA; Shubin FN; Besednova NN
Antibiot Khimioter; 1996 Jan; 41(1):19-21. PubMed ID: 8762820
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of the newer beta-lactam and quinolone antimicrobial agents against Pseudomonas pseudomallei.
Ashdown LR
Antimicrob Agents Chemother; 1988 Sep; 32(9):1435-6. PubMed ID: 3196005
[TBL] [Abstract][Full Text] [Related]
12. Yersinia pseudotuberculosis infection of a lumbar facet joint.
Cormier G; Lucas V; Varin S; Hamelin JP; Tanguy G
Joint Bone Spine; 2007 Jan; 74(1):110-1. PubMed ID: 17197222
[No Abstract] [Full Text] [Related]
13. How predictable is development of resistance after beta-lactam therapy in Enterobacter cloacae infection?
Michéa-Hamzehpour M; Pechère JC
J Antimicrob Chemother; 1989 Sep; 24(3):387-95. PubMed ID: 2808193
[TBL] [Abstract][Full Text] [Related]
14. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.
Zhang Y; Bliska JB
Infect Immun; 2010 May; 78(5):2329-41. PubMed ID: 20231414
[TBL] [Abstract][Full Text] [Related]
15. Septic shock due to Yersinia pseudotuberculosis infection in an adult immunocompetent patient: a case report and literature review.
Hashimoto T; Takenaka R; Fukuda H; Hashinaga K; Nureki SI; Hayashidani H; Sakamoto T; Shigemitsu O
BMC Infect Dis; 2021 Jan; 21(1):36. PubMed ID: 33413171
[TBL] [Abstract][Full Text] [Related]
16. Novel diagnostic ELISA test for discrimination between infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
Wielkoszynski T; Moghaddam A; Bäckman A; Broden J; Piotrowski R; Mond-Paszek R; Kozarenko A; Ny T; Wilczynska M
Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2301-2306. PubMed ID: 30238343
[TBL] [Abstract][Full Text] [Related]
17. [Ciprofloxacin after clinical failure of beta-lactam antibiotics in children with salmonellosis].
Moulin F; Sauvé-Martin H; Marc E; Lorrot MM; Soulier M; Ravilly S; Raymond J; Gendrel D
Arch Pediatr; 2003 Jul; 10(7):608-14. PubMed ID: 12907068
[TBL] [Abstract][Full Text] [Related]
18. Yersinia pseudotuberculosis in stool from patients in a regional Belgian hospital.
Van Noyen R; Selderslaghs R; Bogaerts A; Verhaegen J; Wauters G
Contrib Microbiol Immunol; 1995; 13():19-24. PubMed ID: 8833787
[No Abstract] [Full Text] [Related]
19. Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.
Fournier JL; Ramisse F; Jacolot AC; Szatanik M; Petitjean OJ; Alonso JM; Scavizzi MR
Antimicrob Agents Chemother; 1996 Feb; 40(2):325-30. PubMed ID: 8834874
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics.
Hornstein MJ; Jupeau AM; Scavizzi MR; Philippon AM; Grimont PA
Antimicrob Agents Chemother; 1985 May; 27(5):806-11. PubMed ID: 2990327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
